Comparison of Real-World Dose and Consumption for Two Extended Half-Life Recombinant Factor VIII Products for the Treatment of Hemophilia A in the United States by Wu Y, Sun SX, Fan T

Get full text

The Impact of Pharmacokinetic-Guided Prophylaxis on Clinical Outcomes and Healthcare Resource Utilization in Hemophilia A Patients: Real-World Evidence from the CHESS II Study by Ferri Grazzi E, Sun SX, Burke T, O'Hara J

Get full text

Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis by AbuDagga A, Sun SX, Tan H, Solem CT

Get full text

A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world by Wan Y, Sun SX, Corman S, Huang X, Gao X, Shorr AF

Get full text

Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey by Solem CT, Sun SX, Liu S, Macahilig C, Katyal M, Gao X, Shorr AF

Get full text

Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials by Rennard SI, Sun SX, Tourkodimitris S, Rowe P, Goehring UM, Bredenbröker D, Calverley PM

Get full text

Biophysics at the coffee shop: lessons learned working with George Oster by Igoshin, OA, Chen, J, Xing, J, Liu, J, Elston, TC, Grabe, M, Kim, KS, Nirody, JA, Rangamani, P, Sun, SX, Wang, H, Wolgemuth, C